781.30 66.20 (9.26%)

53.36% Fall from 52W High

3.6M NSE+BSE Volume

High volume+gain today

NSE 29 May, 2025 3:31 PM (IST)



Board Meetings - Strides Pharma Science Ltd.

The latest board meeting for Strides Pharma Science Ltd. took place on 22 May 2025, for the purpose of Audited Results & Final Dividend

Ex-date Purpose Notes
22 May 2025 Audited Results & Final Dividend -
30 Jan 2025 Quarterly Results -
24 Oct 2024 Quarterly Results -
29 Jul 2024 Quarterly Results -
22 May 2024 Audited Results & Final Dividend -
30 Jan 2024 Quarterly Results -
30 Oct 2023 Quarterly Results -
25 Sep 2023 Scheme of Arrangement -
02 Aug 2023 Quarterly Results -
25 May 2023 Audited Results & Final Dividend -
24 Jan 2023 Quarterly Results -
14 Nov 2022 Quarterly Results -
29 Jul 2022 Quarterly Results -
25 Jul 2022 Others Inter alia, to consider and approve Intimation of raising of funds by way of issuance of Non-Convertible Debentures under Regulation 29 of SEBI Listing Regulations.
24 May 2022 Audited Results & Dividend -
10 Feb 2022 Quarterly Results & Others To consider Fund Raising (Revised)
10 Nov 2021 Quarterly Results -
06 Aug 2021 Quarterly Results -
27 May 2021 Audited Results -
04 Feb 2021 Quarterly Results -
29 Oct 2020 Quarterly Results -
05 Aug 2020 Quarterly Results -
20 May 2020 Audited Results & Dividend -
30 Jan 2020 Quarterly Results -
25 Oct 2019 Others -
29 Jul 2019 Quarterly Results & Interim Dividend -
10 May 2019 Audited Results & Dividend -
29 Jan 2019 Quarterly Results -
31 Oct 2018 Quarterly Results -
08 Aug 2018 Quarterly Results -
18 May 2018 Audited Results & Dividend -
09 Feb 2018 Quarterly Results -
31 Oct 2017 Quarterly Results -
11 Aug 2017 Quarterly Results -
18 May 2017 Audited Results & Dividend -
03 Feb 2017 Quarterly Results -
28 Oct 2016 Quarterly Results -
17 Aug 2016 Quarterly Results -
16 May 2016 Audited Results & Dividend -
08 Feb 2016 Quarterly Results -
27 Oct 2015 Quarterly Results -
30 Jul 2015 Quarterly Results -
22 May 2015 Audited Results & Dividend Allotted 10,000 fully paid equity shares of Rs.10/- each under the Strides Arcolab ESOP 2011 Scheme of the Company.
02 Feb 2015 Quarterly Results -
07 Nov 2014 Quarterly Results -
07 Oct 2014 Special Dividend -
25 Jul 2014 Quarterly Results -
23 May 2014 Audited Results & Dividend -
07 Feb 2014 Quarterly Results -
10 Dec 2013 Special Dividend -
14 Nov 2013 Quarterly Results -
25 Jul 2013 Quarterly Results -
25 Apr 2013 Quarterly Results -
28 Feb 2013 Audited Results & Dividend -
19 Oct 2012 Quarterly Results -
27 Jul 2012 Quarterly Results -
26 Apr 2012 Quarterly Results -
27 Feb 2012 Audited Results & Dividend -
24 Oct 2011 Quarterly Results -
27 Jul 2011 Quarterly Results -
25 Apr 2011 Quarterly Results -
24 Feb 2011 Audited Results & Dividend -
27 Oct 2010 Quarterly Results -
27 Jul 2010 Quarterly Results -
22 Apr 2010 Quarterly Results -
24 Feb 2010 Audited Results & Dividend -
30 Oct 2009 Quarterly Results -
30 Jul 2009 Quarterly Results -
24 Apr 2009 Quarterly Results -
13 Apr 2009 Others inter alia, to consider various options of reorganizing the business of the Company and its Subsidiary Companies.
25 Feb 2009 Audited Results & Dividend -
31 Oct 2008 Quarterly Results -
22 Jul 2008 To consider the proposal of Merger inter alia, to Consider the proposal to merge Grandix Pharmaceuticals Ltd, Grandix Laboratories Ltd and Global Remedies (all subsidiaries of the Company) with the Company.
28 Apr 2008 Quarterly Results -
07 Mar 2008 Audited Results & Dividend -
30 Oct 2007 Quarterly Results -
27 Jul 2007 Quarterly Results -
26 Apr 2007 Quarterly Results -
29 Jan 2007 Accounts & Dividend -
27 Oct 2006 Quarterly Results -
26 Jul 2006 Quarterly Results -
25 Apr 2006 Quarterly Results -
01 Mar 2006 General -
09 Feb 2006 Accounts, Dividend & ESOP -
21 Dec 2005 Appointment of Directors -
27 Oct 2005 Quarterly Results -
29 Jul 2005 Quarterly Results -
01 Jun 2005 Acquisition To consider acquiring a majority stake in Biopharma, a Venezuelean marketing company subject to due diligence.
25 Apr 2005 Quarterly Results -
12 Apr 2005 To consider raising of funds To consider the proposal for raising of funds up to an amount not exceeding Rs 550 million through issue of Cumulative Redeemable Preference Shares (CRPS).
25 Mar 2005 Accounts, Dividend & Others Voluntary Delisting of Shares from the Bangalore Stock Exchange Ltd & Mangalore Stock Exchange.
04 Feb 2005 Others To Consider a proposal for issue of foreign currency convertible bonds or such other similar securities to fund the proposed expansion of capacities.
29 Oct 2004 Quarterly Results -
08 Oct 2004 Others Preferential Offer
21 Jul 2004 Quarterly Results -
21 Apr 2004 Half Yearly Results -
19 Jan 2004 Quarterly Results & Others To fix the date,time and venue for holding of an Extra ordianry General Meeting of the Company
04 Sep 2003 Others A proposal for introduction of 'Employee Stock Option Plan 2003" and other related/incidental matters required to implement the same would be considered.
30 Apr 2003 Half Yearly Results -